Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    April 2017
  1. CHEMAITILLY W, Cohen LE
    DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.
    Eur J Endocrinol. 2017;176:R183-R203.
    PubMed     Text format     Abstract available


    March 2017
  2. HANSEN CR, Perrild H, Koefoed BG, Zander M, et al
    Video conferences preceded by uploading of measurements as add-on to standard care among patients with type 2 diabetes not responding to standard regimens - a randomized controlled trial.
    Eur J Endocrinol. 2017 Mar 21. pii: EJE-16-0811. doi: 10.1530/EJE-16-0811.
    PubMed     Text format     Abstract available


  3. HYGUM K, Starup-Linde J, Harslof T, Vestergaard P, et al
    MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
    Eur J Endocrinol. 2017;176:R137-R157.
    PubMed     Text format     Abstract available


  4. SCOTT R, Van Vliet G, Deladoey J
    Association of adrenal insufficiency with insulin-dependent diabetes mellitus in a patient with inactivating mutations in nicotinamide nucleotide transhydrogenase: a phenocopy of the animal model.
    Eur J Endocrinol. 2017;176:C1-C2.
    PubMed     Text format    


    February 2017
  5. MOEN GH, Sommer C, Prasad R, Sletner L, et al
    MECHANISMS IN ENDOCRINOLOGY: EPIGENETIC MODIFICATIONS AND GESTATIONAL DIABETES; A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE.
    Eur J Endocrinol. 2017 Feb 23. pii: EJE-16-1017. doi: 10.1530/EJE-16-1017.
    PubMed     Text format     Abstract available


  6. HJORTEBJERG R, Laugesen E, Hoyem P, Oxvig C, et al
    The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0940. doi: 10.1530/EJE-16-0940.
    PubMed     Text format     Abstract available


  7. GIORDA CB, Carna P, Romeo F, Costa G, et al
    Prevalence, incidence, and associated co-morbidities of treated hypothyroidism. An update from a European population.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0559. doi: 10.1530/EJE-16-0559.
    PubMed     Text format     Abstract available


  8. BRONS C, Grunnet LG
    MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
    Eur J Endocrinol. 2017;176:R67-R78.
    PubMed     Text format     Abstract available


  9. LESEN E, Granfeldt D, Houchard A, Dinet J, et al
    Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.
    Eur J Endocrinol. 2017;176:203-212.
    PubMed     Text format     Abstract available


    January 2017
  10. CHANTZICHRISTOS D, Persson A, Eliasson B, Miftaraj M, et al
    Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study.
    Eur J Endocrinol. 2017;176:31-39.
    PubMed     Text format     Abstract available


    December 2016
  11. LOFVENBORG JE, Andersson T, Carlsson PO, Dorkhan M, et al
    Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes.
    Eur J Endocrinol. 2016;175:605-614.
    PubMed     Text format     Abstract available


    November 2016
  12. BREUER TG, Borker L, Quast DR, Tannapfel A, et al
    Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.
    Eur J Endocrinol. 2016;175:467-76.
    PubMed     Text format     Abstract available


  13. SARDELLA C, Cappellani D, Urbani C, Manetti L, et al
    Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.
    Eur J Endocrinol. 2016;175:443-53.
    PubMed     Text format     Abstract available


    October 2016
  14. SMITS MM, Tonneijck L, Muskiet MH, Hoekstra T, et al
    Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
    Eur J Endocrinol. 2016 Oct 24. pii: EJE-16-0507.
    PubMed     Text format     Abstract available


  15. DE ARAUJO IM, Salmon CE, Nahas AK, Nogueira-Barbosa MH, et al
    Marrow Adipose Tissue Spectrum in Obesity and Type 2 Diabetes Mellitus.
    Eur J Endocrinol. 2016 Oct 5. pii: EJE-16-0448.
    PubMed     Text format     Abstract available


  16. KURSTJENS S, De Baaij J, Bouras H, Bindels R, et al
    Determinants of hypomagnesemia in patients with type 2 diabetes mellitus.
    Eur J Endocrinol. 2016 Oct 5. pii: EJE-16-0517.
    PubMed     Text format     Abstract available


  17. SBARDELLA E, Joseph RN, Jafar-Mohammadi B, Isidori AM, et al
    Pituitary stalk thickening: the role of an innovative MRI imaging analysis which may assist in determining clinical management.
    Eur J Endocrinol. 2016;175:255-63.
    PubMed     Text format     Abstract available


    September 2016
  18. ZAHARENKO L, Kalnina I, Geldnere K, Konrade I, et al
    Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
    Eur J Endocrinol. 2016 Sep 8. pii: EJE-16-0347.
    PubMed     Text format     Abstract available


  19. CARREIRO MP, Lauria MW, Naves GN, Miranda PA, et al
    Seventy two-hour glucose monitoring profiles in mild gestational diabetes mellitus: differences from healthy pregnancies and influence of diet counseling.
    Eur J Endocrinol. 2016;175:201-9.
    PubMed     Text format     Abstract available


  20. DAL J, Feldt-Rasmussen U, Andersen M, Kristensen LO, et al
    Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study.
    Eur J Endocrinol. 2016;175:181-90.
    PubMed     Text format     Abstract available


    August 2016
  21. LARCHER S, Gauchez AS, Lablanche S, Pepin JL, et al
    Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag.
    Eur J Endocrinol. 2016 Aug 16. pii: EJE-16-0188.
    PubMed     Text format     Abstract available


  22. HERDER C, Faerch K, Carstensen-Kirberg M, Lowe G, et al
    Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study.
    Eur J Endocrinol. 2016 Aug 4. pii: EJE-16-0528.
    PubMed     Text format     Abstract available


  23. WU XY, Lam VC, Yu YF, Ho RS, et al
    Epidemiological characteristics and methodological quality of meta-analyses on diabetes mellitus treatment: a systematic review.
    Eur J Endocrinol. 2016 Aug 4. pii: EJE-16-0172.
    PubMed     Text format     Abstract available


  24. KRUL-POEL YH, Ter Wee M, Lips P, Simsek S, et al
    MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with Type 2 Diabetes Mellitus: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Aug 2. pii: EJE-16-0391.
    PubMed     Text format     Abstract available


    July 2016
  25. VAN RAALTE DH, Bunck MC, Smits MM, Hoekstra T, et al
    Exenatide Improves Beta-cell Function up to 3 Years of Treatment in Patients with Type 2 Diabetes: a Randomised Controlled Trial.
    Eur J Endocrinol. 2016 Jul 27. pii: EJE-16-0286.
    PubMed     Text format     Abstract available


  26. NOCTOR E, Crowe C, Carmody LA, Saunders JA, et al
    Abnormal glucose tolerance post-gestational diabetes mellitus as defined by International Association of Diabetes and Pregnancy Study Groups criteria.
    Eur J Endocrinol. 2016 Jul 15. pii: EJE-15-1260.
    PubMed     Text format     Abstract available


  27. DAVIS TM, Chubb SA, Davis W
    The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: The Fremantle Diabetes Study.
    Eur J Endocrinol. 2016 Jul 14. pii: EJE-16-0327.
    PubMed     Text format     Abstract available


    June 2016
  28. STEFFENSEN C, Pereira AM, Dekkers OM, Jorgensen JO, et al
    DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in Type 2 Diabetes patients: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Jun 27. pii: EJE-16-0434.
    PubMed     Text format     Abstract available


  29. LI P, Shan Z, Zhou L, Xie M, et al
    MECHANISMS IN ENDOCRINOLOGY: Parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis.
    Eur J Endocrinol. 2016 Jun 22. pii: EJE-16-0321.
    PubMed     Text format     Abstract available


    March 2016
  30. SMIT J, Sogaard M, Schonheyder HC, Nielsen H, et al
    Diabetes and risk of community-acquired Staphylococcus aureus bacteremia: A population-based case-control study.
    Eur J Endocrinol. 2016 Mar 10. pii: EJE-16-0023.
    PubMed     Text format     Abstract available


  31. LENG J, Liu G, Zhang C, Xin S, et al
    Physical Activity, Sedentary Behaviors and Risk of Gestational Diabetes Mellitus: A Population-Based Cross-Sectional Study in Tianjin, China.
    Eur J Endocrinol. 2016 Mar 10. pii: EJE-15-1103.
    PubMed     Text format     Abstract available


  32. THEILADE S, Rossing P, Eugen-Olsen J, Jensen JS, et al
    Plasma soluble urokinase plasminogen activator receptor (suPAR) level is associated with myocardial impairment assessed with advanced echocardiography in Type 1 Diabetes Patients with normal ejection fraction and without known heart disease or end sta
    Eur J Endocrinol. 2016 Mar 7. pii: EJE-15-0986.
    PubMed     Text format     Abstract available


    February 2016
  33. NIELSEN ML, Pareek M, Leosdottir M, Hojlund K, et al
    Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetes.
    Eur J Endocrinol. 2016 Feb 12. pii: EJE-15-1221.
    PubMed     Text format     Abstract available


  34. MAST R, Jansen AP, Walraven I, Rauh SP, et al
    Time to insulin initiation and long term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study.
    Eur J Endocrinol. 2016 Feb 2. pii: EJE-15-1149.
    PubMed     Text format     Abstract available


    January 2016
  35. SANTI D, Granata AR, Guidi A, Pignatti E, et al
    Six months of daily treatment with Vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial.
    Eur J Endocrinol. 2016 Jan 20. pii: EJE-15-1100.
    PubMed     Text format     Abstract available


  36. SCHAMAREK I, Herder C, Nowotny B, Carstensen-Kirberg M, et al
    Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
    Eur J Endocrinol. 2016 Jan 5. pii: EJE-15-1010.
    PubMed     Text format     Abstract available


    December 2015
  37. COOPE A, Torsoni AS, Velloso L
    MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes.
    Eur J Endocrinol. 2015 Dec 8. pii: EJE-15-1065.
    PubMed     Text format     Abstract available


  38. JUAN-MATEU J, Villate O, Eizirik DL
    MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.
    Eur J Endocrinol. 2015 Dec 1. pii: EJE-15-0916.
    PubMed     Text format     Abstract available


  39. SANTOS A, Resmini E, Gomez-Anson B, Crespo I, et al
    Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Eur J Endocrinol. 2015;173:765-75.
    PubMed     Text format     Abstract available


    November 2015
  40. KOSKINEN MK, Helminen O, Matomaki J, Aspholm S, et al
    Reduced beta-cell function in early preclinical type 1 diabetes.
    Eur J Endocrinol. 2015 Nov 30. pii: EJE-15-0674.
    PubMed     Text format     Abstract available


  41. BARCHETTA I, Alessandri C, Bertoccini L, Cimini FA, et al
    Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile.
    Eur J Endocrinol. 2015 Nov 17. pii: EJE-15-0791.
    PubMed     Text format     Abstract available


  42. FACCINETTI NI, Guerra LL, Penas-Steinhardt A, Iacono RF, et al
    Characterization of Zinc Transporter 8 antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric and heterodimeric ZnT8 antigen variants.
    Eur J Endocrinol. 2015 Nov 13. pii: EJE-15-0681.
    PubMed     Text format     Abstract available


  43. TIAN M, Liang Z, Liu R, Li K, et al
    Effects of Sitagliptin on circulating Zinc-alpha2-Glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial.
    Eur J Endocrinol. 2015 Nov 6. pii: EJE-15-0637.
    PubMed     Text format     Abstract available


  44. HOUGH S, Pierroz D, Cooper C, Ferrari S, et al
    MECHANISMS IN ENDOCRINOLOGY: Mechanisms and Evaluation of Bone Fragility in Type 1 Diabetes Mellitus.
    Eur J Endocrinol. 2015 Nov 4. pii: EJE-15-0820.
    PubMed     Text format     Abstract available


  45. SHANBHOGUE VV, Hansen S, Frost M, Jorgensen NR, et al
    Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease.
    Eur J Endocrinol. 2015 Nov 4. pii: EJE-15-0860.
    PubMed     Text format     Abstract available


    October 2015
  46. DI DALMAZI G, Pasquali R, Beuschlein F, Reincke M, et al
    Subclinical hypercortisolism: a state, a syndrome, or a disease?
    Eur J Endocrinol. 2015;173:M61-71.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: